Amphetamine causes dopamine depletion and cell death in the mouse olfactory bulb

European Journal of Pharmacology

Volumn 589, Issue 1-3, 2008, Pages 94-97

  Atianjoh, Fidelis E ^a   Ladenheim, Bruce ^a   Krasnova, Irina N ^a   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

DNA fragmentation; Neurotoxicity; Striatum; TUNEL staining

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; AMPHETAMINE; DNA FRAGMENT; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG DEPENDENCE; HISTOPATHOLOGY; MALE; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NEUROTOXICITY; NICK END LABELING; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL;

AMPHETAMINE; ANIMALS; CELL DEATH; CENTRAL NERVOUS SYSTEM STIMULANTS; DNA FRAGMENTATION; DOPAMINE; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; IN SITU NICK-END LABELING; INJECTIONS; MALE; MICE; OLFACTORY BULB; TIME FACTORS;

EID: 47749113637     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.05.001     Document Type: Article

References (33)

1. Boniatti M.M., Zubaran C., Panarotto D., Delazeri G.J., Tirello J.L., Feldens M.O., and Sperotto V.F. The use of psychoactive substances among medical students in southern Brazil. Drug Alcohol Rev. 26 (2007) 279-285
2. Cadet J.L., Krasnova I.N., Jayanthi S., and Lyles J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res. 11 (2007) 183-202
3. Davila N.G., Blakemore L.J., and Trombley P.Q. Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. J. Neurophysiol. 90 (2003) 395-404
4. Deng X., Ladenheim B., Jayanthi S., and Cadet J.L. Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb. Biol. Psychiatry 61 (2007) 1235-1243
5. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., and Hanson G.R. New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 681-698
6. Halasz N., Johansson O., Hokfelt T., Ljungdahl A., and Goldstein M. Immunohistochemical identification of two types of dopamine neuron in the rat olfactory bulb as seen by serial sectioning. J. Neurocytol. 10 (1981) 251-259
7. Hawkes C. Olfaction in neurodegenerative disorder. Mov. Disord. 18 (2003) 364-372
8. Holmgren A., Holmgren P., Kugelberg F.C., Jones A.W., and Ahlner J. Predominance of illicit drugs and poly-drug use among drug-impaired drivers in Sweden. Traffic Inj. Prev. 8 (2007) 361-367
9. Hsia A.Y., Vincent J.D., and Lledo P.M. Dopamine depresses synaptic inputs into the olfactory bulb. J. Neurophysiol. 82 (1999) 1082-1085
10. Huang N.K., Wan F.J., Tseng C.J., and Tung C.S. Amphetamine induces hydroxyl radical formation in the striatum of rats. Life Sci. 61 (1997) 2219-2229
11. Huisman E., Uylings H.B., and Hoogland P.V. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov. Disord. 19 (2004) 687-692
12. Jakab R.L., and Bowyer J.F. Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke. Brain Res. 958 (2002) 52-69
13. Krasnova I.N., Bychkov E.R., Lioudyno V.I., Zubareva O.E., and Dambinova S.A. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats. Neuroscience 95 (2000) 113-117
14. Krasnova I.N., Ladenheim B., and Cadet J.L. Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway. Faseb J. 19 (2005) 851-853
15. Krasnova I.N., Ladenheim B., Jayanthi S., Oyler J., Moran T.H., Huestis M.A., and Cadet J.L. Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation. Neuroscience 107 (2001) 265-274
16. Ladenheim B., Krasnova I.N., Deng X., Oyler J.M., Polettini A., Moran T.H., Huestis M.A., and Cadet J.L. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol. Pharmacol. 58 (2000) 1247-1256
17. Lledo P.M., Alonso M., and Grubb M.S. Adult neurogenesis and functional plasticity in neuronal circuits. Nat. Rev. Neurosci. 7 (2006) 179-193
18. McKetin R., and Mattick R.P. Attention and memory in illicit amphetamine users. Drug Alcohol Depend. 48 (1997) 235-242
19. Ornstein T.J., Iddon J.L., Baldacchino A.M., Sahakian B.J., London M., Everitt B.J., and Robbins T.W. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23 (2000) 113-126
20. Paterson N.E., and Markou A. Animal models and treatments for addiction and depression co-morbidity. Neurotox. Res. 11 (2007) 1-32
21. Pause B.M., Miranda A., Goder R., Aldenhoff J.B., and Ferstl R. Reduced olfactory performance in patients with major depression. J. Psychiatr. Res. 35 (2001) 271-277
22. Peat M.A., Warren P.F., Bakhit C., and Gibb J.W. The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine. Eur. J. Pharmacol. 116 (1985) 11-16
23. Philpot B.D., Men D., McCarty R., and Brunjes P.C. Activity-dependent regulation of dopamine content in the olfactory bulbs of naris-occluded rats. Neuroscience 85 (1998) 969-977
24. Ricaurte G.A., Schuster C.R., and Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193 (1980) 153-163
25. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., Baker N.B., Hunter J., Carthy T., Booker E., London M., Deakin J.F., Sahakian B.J., and Robbins T.W. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20 (1999) 322-339
26. Rolls E.T. Taste, olfactory, and food texture processing in the brain, and the control of food intake. Physiol. Behav. 85 (2005) 45-56
27. Ryan L.J., Linder J.C., Martone M.E., and Groves P.M. Histological and ultrastructural evidence that d-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res. 518 (1990) 67-77
28. Satoh S., Morita N., Matsuzaki I., Konishi T., Nakano T., Minoshita S., Arizono H., Saito S., and Ayabe A.S. Relationship between odor perception and depression in the Japanese elderly. Psychiatry Clin. Neurosci. 50 (1996) 271-275
29. Shoblock J.R., Maisonneuve I.M., and Glick S.D. Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacology (Berl). 170 (2003) 150-156
30. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., and Glick S.D. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl). 165 (2003) 359-369
31. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 29 (2005) 627-647
32. Teter C.J., McCabe S.E., LaGrange K., Cranford J.A., and Boyd C.J. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26 (2006) 1501-1510
33. Wagner G.C., Ricaurte G.A., Johanson C.E., Schuster C.R., and Seiden L.S. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30 (1980) 547-550